[go: up one dir, main page]

PELEG et al., 1986 - Google Patents

Distribution of catecholamines between fetal and maternal compartments during human pregnancy with emphasis on L-dopa and dopamine

PELEG et al., 1986

Document ID
305264934112246675
Author
PELEG D
MUNSICK R
DIKER D
GOLDMAN J
BEN-JONATHAN N
Publication year
Publication venue
The Journal of Clinical Endocrinology & Metabolism

External Links

Snippet

This study was undertaken to determine the differential distribution of catecholamines, in particular L-dihydroxyphenylalanine (L-dopa) and dopamine, between the fetal and maternal compartments during human pregnancy. Amniotic fluid and fetal and maternal …
Continue reading at academic.oup.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems

Similar Documents

Publication Publication Date Title
Kirkinen et al. The effect of caffeine on placental and fetal blood flow in human pregnancy
Anai et al. Vaginal fluid hCG levels for detecting premature rupture of membranes
Cetin et al. Fetal plasma leptin concentrations: relationship with different intrauterine growth patterns from 19 weeks to term
Friedman et al. Serum testosterone concentrations in the evaluation of androgen-producing tumors
Ostlund et al. Insulin-like growth factor I in fetal serum obtained by cordocentesis is correlated with intrauterine growth retardation.
Rodeck et al. Testosterone levels in midtrimester maternal and fetal plasma and amniotic fluid
PELEG et al. Distribution of catecholamines between fetal and maternal compartments during human pregnancy with emphasis on L-dopa and dopamine
Castelbaum et al. Timing of the endometrial biopsy may be critical for the accurate diagnosis of luteal phase deficiency
Emery et al. Antenatal diagnosis and aminoacid composition of amniotic fluid
Kass et al. Pituitary gonadal dysfunction in adolescents with varicocele
Pakravan et al. Familial congenital absence of adrenal glands; evaluation of glucocorticoid, mineralocorticoid, and estrogen metabolism in the perinatal period
Velkoska Nakova et al. Prevalence of thyroid dysfunction and autoimmunity in pregnant women with gestational and diabetes type 1
Pan et al. Quantification of ovarian stromal Doppler signals in poor responders undergoing in vitro fertilization with three-dimensional power Doppler ultrasonography
Urbanska et al. Is polycystic ovarian syndrome and insulin resistance associated with abnormal uterine bleeding in adolescents?
EDEN et al. The diagnosis of polycystic ovaries in subfertile women
Aksel et al. Effects of clomiphene citrate on cytosolic estradiol and progesterone receptor concentrations in secretory endometrium
Peleg et al. Predominance of L-dopa in fetal plasma and the amniotic fluid during late gestation in the rat
Shields et al. Serum CK-BB isoenzyme in preterm infants with periventricular hemorrhage
Prakash et al. Absence of follicular phase defect in women with recurrent miscarriage
Hamilton et al. Ovulatory disturbances in patients with luteal insufficiency
Oats et al. Angiotensin-converting enzyme and the renin-angiotensin system in normotensive primigravid pregnancy
Barnhart et al. Adrenal cortical function in the postmature fetus and newborn infant
Tornehave et al. Placental proteins in peripheral blood and tissues of ectopic pregnancies
Zuspan et al. Alterations of urinary epinephrine and norepinephrine: The antepartum, intrapartum, and postpartum periods
Sonak et al. A prospective observational study of polycystic ovarian syndrome among adolescent and young girls at tertiary care hospital